Showing results (101-110 of 260) with videos related to
Sort By:
Pageof 26
The Journal of Allergy and Clinical Immunology|July 4, 2016
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterizationSilvia Pesce, Marco Greppi, Giovanna Tabellini, et al.Scientific Reports|July 2, 2024
DOK1 and DOK2 regulate CD8 T cell signaling and memory formation without affecting tumor cell killingVladimir Laletin, Pierre-Louis Bernard, Camille Montersino, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2017
The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T CellsCassie-Marie Peigné, Alexandra Léger, Marie-Claude Gesnel, et al.Oncology Reports|January 8, 2021
Selection of tumor‑resistant variants following sustained natural killer cell‑mediated immune stressThibault Carré, Jerome Thiery, Bassam Janji, et al.Frontiers in Immunology|September 27, 2023
The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancerBasma Zohair, Dounia Chraa, Ibtissam Rezouki, et al.Nature Communications|December 24, 2017
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanomaFlorie Bertrand, Anne Montfort, Elie Marcheteau, et al.Frontiers in Immunology|March 26, 2016
Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsNicolas Dulphy, Anne-Sophie Chrétien, Zena Khaznadar, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Dok-4 is a novel negative regulator of T cell activationAudrey Gérard, Marguerite Ghiotto, Camille Fos, et al.The Journal of Biological Chemistry|August 1, 2012
The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodiesAparna Palakodeti, Andrew Sandstrom, Lakshmi Sundaresan, et al.Blood|January 13, 2004
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemiaMohamad Mohty, Eric Jourdan, Naira Ben Mami, et al.Pageof 26